• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H₄octapa和H₂dedpa的模块化合成以及与⁸⁶Y/⁹⁰Y放射性药物相关的钇配位化学。

Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals.

作者信息

Price Eric W, Cawthray Jacqueline F, Adam Michael J, Orvig Chris

机构信息

Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, BC V6 T 1Z1, Canada.

出版信息

Dalton Trans. 2014 May 21;43(19):7176-90. doi: 10.1039/c4dt00239c. Epub 2014 Mar 28.

DOI:10.1039/c4dt00239c
PMID:24676528
Abstract

The ligands H2dedpa, H4octapa, p-SCN-Bn-H2dedpa, and p-SCN-Bn-H4octapa were synthesized using a new protection chemistry approach, with labile tert-butyl esters replacing the previously used methyl esters as protecting groups for picolinic acid moieties. Additionally, the ligands H2dedpa and p-SCN-Bn-H2dedpa were synthesized using nosyl protection chemistry for the first time. The use of tert-butyl esters allows for deprotection at room temperature in trifluoroacetic acid (TFA), which compares favorably to the harsh conditions of refluxing HCl (6 M) or LiOH that were previously required for methyl ester cleavage. H4octapa has recently been shown to be a very promising (111)In and (177)Lu ligand for radiopharmaceutical applications; therefore, coordination chemistry studies with Y(3+) are described to assess its potential for use with (86)Y/(90)Y. The solution chemistry of H4octapa with Y(3+) is shown to be suitable via solution NMR studies of the Y(octapa) complex and density functional theory (DFT) calculations of the predicted structure, suggesting properties similar to those of the analogous In(3+) and Lu(3+) complexes. The molecular electrostatic potential (MEP) was mapped onto the molecular surface of the DFT-calculated coordination structures, suggesting very similar and even charge distributions between both the Lu(3+) and Y(3+) complexes of octapa(4-), and coordinate structures between 8 (ligand only) and 9 (ligand and one H2O). Potentiometric titrations determined H4octapa to have a formation constant (log K(ML)) with Y(3+) of 18.3 ± 0.1, revealing high thermodynamic stability. This preliminary work suggests that H4octapa may be a competent ligand for future (86)Y/(90)Y radiopharmaceutical applications.

摘要

配体H2dedpa、H4octapa、p-SCN-Bn-H2dedpa和p-SCN-Bn-H4octapa是采用一种新的保护化学方法合成的,用不稳定的叔丁酯取代先前用于吡啶甲酸部分保护基团的甲酯。此外,配体H2dedpa和p-SCN-Bn-H2dedpa首次采用 nosyl保护化学方法合成。叔丁酯的使用允许在室温下于三氟乙酸(TFA)中进行脱保护,这与先前甲酯裂解所需的回流HCl(6 M)或LiOH的苛刻条件相比具有优势。最近已表明H4octapa是用于放射性药物应用的非常有前景的(111)In和(177)Lu配体;因此,描述了与Y(3+)的配位化学研究,以评估其与(86)Y/(90)Y一起使用的潜力。通过对Y(octapa)络合物的溶液核磁共振研究和预测结构的密度泛函理论(DFT)计算表明,H4octapa与Y(3+)的溶液化学性质是合适的,这表明其性质与类似的In(3+)和Lu(3+)络合物相似。分子静电势(MEP)映射到DFT计算的配位结构的分子表面,表明octapa(4-)的Lu(3+)和Y(3+)络合物之间的电荷分布非常相似甚至相同,以及8(仅配体)和9(配体和一个H2O)之间的配位结构。电位滴定法测定H4octapa与Y(3+)的形成常数(log K(ML))为18.3±0.1,显示出高的热力学稳定性。这项初步工作表明,H4octapa可能是未来(86)Y/(90)Y放射性药物应用的合适配体。

相似文献

1
Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals.H₄octapa和H₂dedpa的模块化合成以及与⁸⁶Y/⁹⁰Y放射性药物相关的钇配位化学。
Dalton Trans. 2014 May 21;43(19):7176-90. doi: 10.1039/c4dt00239c. Epub 2014 Mar 28.
2
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.一个碳原子能带来多大的差异:用于铟 - 111和镥 - 177放射化学的H₄octapa与H₄C3octapa配体
Inorg Chem. 2014 Oct 6;53(19):10412-31. doi: 10.1021/ic501466z. Epub 2014 Sep 5.
3
Hoctapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions.霍克塔帕:合成、溶液平衡以及与有用放射性药物金属离子形成的配合物
Dalton Trans. 2017 Oct 31;46(42):14647-14658. doi: 10.1039/c7dt02343j.
4
Rapid Thermodynamically Stable Complex Formation of [In]In, [Y]Y, and [Lu]Lu with Hdappa.[In]In、[Y]Y 和 [Lu]Lu 与 Hdappa 的快速热稳定配合物形成。
Inorg Chem. 2020 May 18;59(10):7238-7251. doi: 10.1021/acs.inorgchem.0c00671. Epub 2020 Apr 27.
5
H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals.用于(67/68)镓和(111)铟放射性药物的H2CHXdedpa和H4CHXoctapa-手性无环螯合配体。
Inorg Chem. 2015 Feb 16;54(4):2017-31. doi: 10.1021/ic502942a. Epub 2015 Jan 26.
6
Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with Lu(III) and Y(III) for radiopharmaceutical applications: Synthesis, DFT calculation, radiolabeling, and in vitro complex stability.含吡啶的八齿配体 NE3TA-PY 与 Lu(III)和 Y(III)形成中性配合物用于放射性药物应用:合成、DFT 计算、放射性标记和体外配合物稳定性。
J Inorg Biochem. 2021 Aug;221:111436. doi: 10.1016/j.jinorgbio.2021.111436. Epub 2021 Apr 24.
7
Stable and Inert Yttrium(III) Complexes with Pyclen-Based Ligands Bearing Pendant Picolinate Arms: Toward New Pharmaceuticals for β-Radiotherapy.具有带吡啶甲酸侧臂的基于Pyclen配体的稳定且惰性的钇(III)配合物:迈向用于β放射治疗的新型药物
Inorg Chem. 2018 Feb 19;57(4):2051-2063. doi: 10.1021/acs.inorgchem.7b02953. Epub 2018 Feb 5.
8
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.螯合剂H4octapa和CHX-A″-DTPA与治疗性放射性金属(90)Y的对比评估。
Nucl Med Biol. 2016 Sep;43(9):566-576. doi: 10.1016/j.nucmedbio.2016.06.004. Epub 2016 Jun 28.
9
Novel "bi-modal" Hdedpa derivatives for radio- and fluorescence imaging.用于放射性和荧光成像的新型“双模态”Hdedpa衍生物。
J Inorg Biochem. 2016 Sep;162:253-262. doi: 10.1016/j.jinorgbio.2015.11.021. Epub 2015 Nov 19.
10
Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga.含硝基咪唑的H2dedpa和H2CHXdedpa衍生物作为潜在的用(68)Ga进行缺氧PET成像的试剂。
Inorg Chem. 2015 May 18;54(10):4953-65. doi: 10.1021/acs.inorgchem.5b00554. Epub 2015 Apr 30.

引用本文的文献

1
Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals.发展钪和钇配位化学以推进诊疗用放射性药物。
Commun Chem. 2020 May 15;3(1):61. doi: 10.1038/s42004-020-0307-0.
2
Toward Ga and Cu Positron Emission Tomography Probes: Is Hdedpa-,'-pram the Missing Link for dedpa Conjugation?向着 Ga 和 Cu 正电子发射断层扫描探针:Hdedpa-,'-pram 是否为 dedpa 缀合的缺失环节?
Inorg Chem. 2023 Dec 18;62(50):20593-20607. doi: 10.1021/acs.inorgchem.2c04123. Epub 2023 Jan 20.
3
The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.
治疗诊断用放射性药物的化学支架:放射性核素、双功能螯合剂和药代动力学修饰连接子。
Molecules. 2022 May 10;27(10):3062. doi: 10.3390/molecules27103062.
4
Rigidified Derivative of the Non-macrocyclic Ligand HOCTAPA for Stable Lanthanide(III) Complexation.用于稳定镧系元素(III)络合的非大环配体HOCTAPA的刚性衍生物
Inorg Chem. 2022 Mar 28;61(12):5157-5171. doi: 10.1021/acs.inorgchem.2c00501. Epub 2022 Mar 11.
5
Coordination chemistry of [Y(pypa)] and comparison immuno-PET imaging of [Sc]Sc- and [Y]Y-pypa-phenyl-TRC105.[Y(pypa)]的配位化学及 [Sc]Sc-和 [Y]Y-pypa-苯丙基-TRC105 的比较免疫 PET 成像。
Dalton Trans. 2020 May 7;49(17):5547-5562. doi: 10.1039/d0dt00437e. Epub 2020 Apr 9.
6
Benzoazacrown compound: a highly effective chelator for therapeutic bismuth radioisotopes.苯并氮杂冠醚化合物:一种用于治疗性铋放射性同位素的高效螯合剂。
Medchemcomm. 2019 Jul 4;10(9):1641-1645. doi: 10.1039/c9md00251k. eCollection 2019 Sep 1.
7
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.螯合剂H4octapa和CHX-A″-DTPA与治疗性放射性金属(90)Y的对比评估。
Nucl Med Biol. 2016 Sep;43(9):566-576. doi: 10.1016/j.nucmedbio.2016.06.004. Epub 2016 Jun 28.
8
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.一个碳原子能带来多大的差异:用于铟 - 111和镥 - 177放射化学的H₄octapa与H₄C3octapa配体
Inorg Chem. 2014 Oct 6;53(19):10412-31. doi: 10.1021/ic501466z. Epub 2014 Sep 5.